Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $100.00. The company’s shares closed last ...

Perioperative posterior cervical muscle plane block decreased numerical pain rating scores vs anesthesia alone in posterior cervical spine surgery.

GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Feb. 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal ... and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling ...

The spinal implants market is estimated to grow by $3.55 billion from 2025 to 2029, according to research from Technavio.

More than 10,000 procedures using Centinel Spine's prodisc cervical total disc replacement system have been completed, the company said Feb. 11.

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...